Nymox Pharmaceutical Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Robinson James George, was filed 26 Jun 2023.
Nymox Pharmaceutical Corp: what insiders have been doing
Nymox Pharmaceutical Corp is a Health Care company. Its directors and officers file their transactions with SEC (Form 4). Nothing new has been filed by managers of Nymox Pharmaceutical Corp in twelve months, the latest record being from 26 June 2023.
Over the whole record (from 2015), the tally stands at 369 purchases and 2 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- -22.7%Entry US$0.31 · Close at T+365 US$0.24
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended December 2024 · cache
- 40,000 shares@ US$0.475.1% of flowCommon StockSEC:0001729637-23-000006:1Canonical exit: 26 Jul 2023 (T+90)
- 40,000 shares@ US$0.45100.0% of flowCommon StockSEC:0001729637-23-000003:0Canonical exit: 24 Jul 2023 (T+90)
- 1,151,515 shares@ US$1.65Common StockSEC:0001640334-22-000918:0Canonical exit: 31 Jul 2022 (T+90)
- 51 shares@ US$2.080.0% of flowCommon StockSEC:0001651844-21-000001:9Canonical exit: 21 Jul 2021 (T+90)
- 200 shares@ US$2.090.0% of flowCommon StockSEC:0001651844-21-000001:13Canonical exit: 21 Jul 2021 (T+90)
- 2,000 shares@ US$2.09Common StockSEC:0001651844-21-000001:0Canonical exit: 20 Jul 2021 (T+90)
- 6,000 shares@ US$2.08Common StockSEC:0001651844-21-000001:1Canonical exit: 20 Jul 2021 (T+90)
- 4,100 shares@ US$2.08Common StockSEC:0001651844-21-000001:2Canonical exit: 20 Jul 2021 (T+90)
- 900 shares@ US$2.08Common StockSEC:0001651844-21-000001:3Canonical exit: 20 Jul 2021 (T+90)
- 7,000 shares@ US$2.07Common StockSEC:0001651844-21-000001:4Canonical exit: 21 Jul 2021 (T+90)
- 1,900 shares@ US$2.13Common StockSEC:0001651844-21-000001:5Canonical exit: 21 Jul 2021 (T+90)
- 3,100 shares@ US$2.11Common StockSEC:0001651844-21-000001:6Canonical exit: 21 Jul 2021 (T+90)
- 5,000 shares@ US$2.05Common StockSEC:0001651844-21-000001:7Canonical exit: 21 Jul 2021 (T+90)
- 4,949 shares@ US$2.09Common StockSEC:0001651844-21-000001:8Canonical exit: 21 Jul 2021 (T+90)
- 800 shares@ US$2.10Common StockSEC:0001651844-21-000001:10Canonical exit: 21 Jul 2021 (T+90)
- 2,900 shares@ US$2.09Common StockSEC:0001651844-21-000001:11Canonical exit: 21 Jul 2021 (T+90)
- 1,100 shares@ US$2.09Common StockSEC:0001651844-21-000001:12Canonical exit: 21 Jul 2021 (T+90)
- 5,834 shares@ US$1.73Common StockSEC:0001651844-19-000023:0Canonical exit: 8 Oct 2019 (T+90)
- 300 shares@ US$1.73Common StockSEC:0001651844-19-000023:1Canonical exit: 8 Oct 2019 (T+90)
- 600 shares@ US$1.72Common StockSEC:0001651844-19-000023:2Canonical exit: 8 Oct 2019 (T+90)
- 166 shares@ US$1.730.0% of flowCommon StockSEC:0001651844-19-000023:3Canonical exit: 8 Oct 2019 (T+90)
- 100 shares@ US$1.720.0% of flowCommon StockSEC:0001651844-19-000023:4Canonical exit: 8 Oct 2019 (T+90)
- 7,000 shares@ US$1.63Common StockSEC:0001651844-19-000022:0Canonical exit: 7 Oct 2019 (T+90)
- 9,000 shares@ US$1.45Common StockSEC:0001651844-19-000021:0Canonical exit: 3 Oct 2019 (T+90)
- 8,000 shares@ US$1.54Common StockSEC:0001651844-19-000020:0Canonical exit: 1 Oct 2019 (T+90)
25 of 371 declarations
About Nymox Pharmaceutical Corp
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing treatments for age-related diseases. It is listed on NASDAQ under the symbol NYMX.
